s-adenosylhomocysteine and Multiple-Myeloma

s-adenosylhomocysteine has been researched along with Multiple-Myeloma* in 1 studies

Other Studies

1 other study(ies) available for s-adenosylhomocysteine and Multiple-Myeloma

Article	Year
5-Aminonaphthalene derivatives as selective nonnucleoside nuclear receptor binding SET domain-protein 2 (NSD2) inhibitors for the treatment of multiple myeloma. European journal of medicinal chemistry, 2021, Oct-15, Volume: 222 Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Histone-Lysine N-Methyltransferase; Humans; Molecular Structure; Multiple Myeloma; Naphthalenes; Repressor Proteins; Structure-Activity Relationship; Tumor Cells, Cultured	2021

Article

Year

5-Aminonaphthalene derivatives as selective nonnucleoside nuclear receptor binding SET domain-protein 2 (NSD2) inhibitors for the treatment of multiple myeloma.

European journal of medicinal chemistry, 2021, Oct-15, Volume: 222

Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Histone-Lysine N-Methyltransferase; Humans; Molecular Structure; Multiple Myeloma; Naphthalenes; Repressor Proteins; Structure-Activity Relationship; Tumor Cells, Cultured

2021